Innovative Eyewear (LUCYW) Form 144: RSU-Derived Sale on 08/19/2025
Rhea-AI Filing Summary
Form 144 notice for Innovative Eyewear, Inc. (ticker LUCYW) shows a proposed sale of 1,670 common shares through Raymond James on 08/19/2025 on NASDAQ with an aggregate market value of $3,317.35. The filing reports the securities were acquired as an RSU grant from the issuer on 08/19/2025, with 5,400 units acquired and payment marked as cash. The issuer’s total shares outstanding are listed as 4,574,602. The filer certifies they are not aware of undisclosed material adverse information and indicates no securities sold in the prior three months.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine small insider sale disclosed; transaction size is immaterial to company capitalization.
The filing documents a small proposed sale of 1,670 common shares valued at $3,317.35, originating from RSUs granted and acquired on the same date as the planned sale. Given the issuer's outstanding share count of 4,574,602, the transaction represents a negligible portion of equity and is unlikely to move market valuation. The report appears compliant with Rule 144 disclosure requirements and contains no indicators of material, nonpublic developments.
TL;DR: Disclosure aligns with insider selling rules; signer affirms no undisclosed material information.
The notice properly identifies the broker, planned sale date, and the RSU origin of the shares, and includes the required representation about material nonpublic information. The filing shows no prior sales in the past three months, which is relevant for aggregation rules. This is a routine Section 144 filing and raises no governance red flags based on the provided information.